Archive | Melanoma In The News

Drug combination delivered by nanoparticles may help in melanoma treatment

HERSHEY, Pa. — The first of a new class of medication that delivers a combination of drugs by nanoparticle may keep melanoma from becoming resistant to treatment, according to Penn State College of Medicine researchers.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

New driver, target in advanced mucosal melanoma

Not all melanomas are created equal. While most melanomas appear on the skin as the result of sun exposure, a small subset of melanomas arise spontaneously from mucosal tissues. And while targeted treatments and immunotherapies have dramatically improved the prognosis for many patients with sun-associated melanomas, these treatments are ineffective in the mucosal form of […]

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma Takes Advantage of Missing Tumor-Suppressors to Resist Immunotherapy

Missing tumor-suppressing genes are the culprit behind resistance to immune checkpoint blockade drugs, investigators recently found.

Read the full story

Posted in Melanoma In The News

Array BioPharma And Columbus’s Egg

In my first articles as a Seeking Alpha contributor, I’ve highlighted the potential of three widely differing companies: Bristol-Myers Squibb (NYSE:BMY), Tracon (NASDAQ:TCON) and Innate Pharma (OTCPK:IPHYF).

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories